<DOC>
	<DOCNO>NCT01976728</DOCNO>
	<brief_summary>To compare ovulation rate woman primary amenorrhea hypogonadotropic hypogonadism follow pulsatile gonadotropin-releasing hormone ( GnRH ) treatment use OmniPod pump versus placebo</brief_summary>
	<brief_title>LutrePulse Hypogonadotropic Hypogonadism</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Amenorrhea</mesh_term>
	<criteria>Women 1840 year old Body mass index ( BMI ) 18 38 kg/m2 Clinical history recently diagnose primary amenorrhea hypogonadotropic hypogonadism Hormonal value centrally analyze fast blood sample : FSH &lt; 5 IU/L mean LH &lt; 5 IU/L Desire become pregnant Discontinued estrogenprogesterone replacement therapy least 1 month screen Negative progestin challenge test perform screen PAP smear within 24 month initial visit Normal stable CT scan MRI scan hypothalamic pituitary region Prolactin thyroidstimulating hormone ( TSH ) within normal clinical laboratory limit Male partner normal semen analysis , include volume , liquefaction time , sperm count , motility , accord local laboratory normal criterion , within past year Normal transvaginal ultrasound screen respect uterus adnexa ( presence ovary tube , without evidence clinically significant abnormality ) normal uterine cavity normal cervix Tube patency saline tubal perfusion , hysterosalpingography laparoscopy file within past 2 year Any medical condition may interfere absorption , distribution , metabolism , excretion drug A history , currently diagnose clinically important cardiovascular , pulmonary ( e.g . serious corticosteroiddependent asthma ) , gastrointestinal , hepatic , metabolic , renal , endocrinological ( e.g . insulin dependent diabetes mellitus ) , neurological ( e.g . epilepsy , serious migraine , central nervous system ( CNS ) lesion ( case hypogonadotropic hypogonadism secondary CNS lesion treatment ) abnormality A history adrenal uncontrolled thyroid disorder , hyperprolactinemia Prior treatment cycle gonadotropins GnRH within last 2 month Known allergy study drug component Infection human immunodeficiency virus ( HIV ) , hepatitis B hepatitis C Ovarian enlargement cyst unknown etiology Abnormal gynecological bleeding undetermined origin Previous current hormonedependent tumor Known active substance abuse Planning undergo vitro fertilization procedure course study treatment cycle Currently undergo treatment gonadotropin hormone ( FSH LH ) , psychotropic medication , sex hormone , medication know interfere normal reproductive function affect GnRH secretion ( e.g . neuroleptic , dopamine antagonist , spironolactone , levodopa , phenothiazine , digoxin ) Ongoing pregnancy lactation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>